DEVELOPMENT OF MURINE STEM CELLS WITH CONDITIONAL KNOCKOUT OF HUMANIZED SNCA GENE
Authors:
Open Access
- 12 February 2023
- journal article
- research article
- Published by Volgograd State Medical University in Pharmacy & Pharmacology
- Vol. 10 (6) , 525-535-535
Abstract
α-synuclein is one of the key molecular links in the pathogenesis of Parkinson’s disease. The accumulated data indicate that pathogenic mutations in theSncagene are associated with the development of neurodegenerative brain damage, indicating the relevance of studying the synuclein neurobiological role.The aimof the study was to create a genetically modified clone of mouse stem cells with a conditional knockout of humanized α-synuclein, which can be used for the reinjection into mouse blastocysts, as well as for basic and appliedin vitroresearch in the field of pathophysiology and neuropharmacology.Materials and methods.To create mouse stem cells with a conditional knockout of the humanizedSncagene, a previously obtained clone with the firstSncaexon flanked by LoxP sites, was used. The CRISPR/Cas9-mediated homologous recombination system with donor DNA oligonucleotides of the human sites of the corresponding gene sites was used to humanize the fourth and fifth exons. Cas9 nuclease, single guide RNA, and donor DNA were transfected into mouse cells.Results.An approach to obtaining clones of mouse genetically modified stem cells expressing pathological humanized α-synuclein, has been proposed and implemented. The resulting clones were plated on Petri dishes for propagation and a further genetic analysis. Clone 126-2F4 was found out carrying the necessary genetic modifications. The results obtained are fundamentally important not only for understanding the development of the pathological process in α-synucleinopathies, but which is more important, for the development of new therapeutic approaches that will stop the extension of the human α-synuclein aggregation pathology throughout the nervous system, and the validation of these approaches in preclinical trials.Conclusion.As a result of the study, a strategy for CRISPR/Cas9-assisted homologous recombination in the genome of mouse embryonic stem cells has been developed to create a fully humanizedSncagene encoding α-synuclein, and the clone genome of mouse embryonic stem cells has been edited using a CRISPR technology. The RNA and DNA oligonucleotides necessary for the creation of RNP complexes that carry out a directed homologous recombination in theSncalocus of the mouse genome have been synthesized. The developed cell clone can serve to create a line of genetically modified mice that serve as a test system for pathophysiological and neuropharmacological studies associated with synucleinopathies. Herewith, before the induction of the Cre-dependent recombination, this line is a representative model for studying a biological role of mutantSnca. At the same time, after a Cre-dependent knockout activation, it is possible to imitate the pharmacological inhibition of α-synuclein, which is of particular interest for applied research in neuropharmacology.Keywords
This publication has 24 references indexed in Scilit:
- A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expressionScientific Reports, 2015
- Lipid peroxidation is essential for α‐synuclein‐induced cell deathJournal of Neurochemistry, 2015
- The many faces of α-synuclein: from structure and toxicity to therapeutic targetNature Reviews Neuroscience, 2012
- The Central Theme of Parkinson’s Disease: α-SynucleinMolecular Neurobiology, 2012
- α-Synuclein misfolding and Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in VitroScience, 2010
- α-Synuclein binding to rab3a in multiple system atrophyNeuroscience Letters, 2005
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous systemNeuron, 1995